Dominion Lending Centres Clearlease Reports Theratechnologies (TSX:TH) seeks European marketing for AIDS-related treatment drug Tesamorelin

Dominion Lending Centres Clearlease Reports Theratechnologies (TSX:TH) seeks European marketing for AIDS-related treatment drug Tesamorelin

VANCOUVER, BC (June 6, 2011) Dominion Lending Centres Clearlease Reports Theratechnologies Inc. (TSX:TH) says it has applied to sell its lead drug tesamorelin in Europe.

The Montreal company said Monday June 6, 2011 taht its partner, Ferrer Internacional S.A., has filed an application in Europe to market the drug, which treats excess abdominal fat in adult HIV-infected patients.

The drug has already received marketing approval in the United States.

Theratechnologies said there are no approved treatments to treat about 212,000 HIV-infected patients in Europe affected by lipodystrophy — a medical condition characterized by abnormal or degenerative loss of fat.

“This European regulatory filing for tesamorelin constitutes an important step forward in meeting our corporate objective of maximizing the commercial potential of our flagship product in major markets,” said John-Michel Huss, president and CEO of Theratechnologies.

“This also represents an important step towards addressing a critical, yet unmet medical need for HIV-infected patients with lipodystrophy throughout the European Union. We were very pleased to obtain FDA approval for tesamorelin in the U.S. and we are confident that our ability to help meet these patient needs, in partnership with Ferrer, will also be recognized in Europe.”

Under a distribution and licensing agreement between the two companies, privately owned Spanish drug maker Ferrer holds the commercialization rights to tesamorelin in Europe.

If approved, tesamorelin will receive marketing authorization for the 27 European Union member countries as well as for Iceland, Liechtenstein and Norway.

In trading on the Toronto Stock Exchange, Theratechnologies shares fell 10 cents to $4.34, a drop of 2.25 per cent.

Video Link: http://youtu.be/f_kk7WJa7Uk

For more information please visit us at: http://www.clearlease.com/Career-Opportunities.html

About Dominion Lending Centres Clearlease

Dominion Lending Centres Clearlease Commercial (DLC Clearlease/Clearlease.com) is a fully diversified Lease Finance Mortgage Banking Brokerage Company specializing in Equipment Leasing, Automobile Leasing, Residential, Commercial Lending/Mortgage Financing. DLC Clearlease possesses the capability to accommodate financing needs ranging from a small second Home Mortgage to a Multi-Million Dollar Commercial Projects. No mortgage is too small or too large for this integrated Company.

Equipment Lease Financing in Vancouver, Surrey, Delta, Richmond, Langley, New Westminster, North Vancouer, West Vancouver, B.C. Also offering Automobile Lease Financing and Mortgage information. Founded by the Pidgeon brothers.

You may have recently seen a Dominion Lending advertisement on such media outlets as: Global News, CTV News, CBC Television, Rogers Sportsnet or possibly heard the great Don Cherry, a Canadian Sports legend, discuss Dominion Lending Centres.

Contact DLC Clearlease.com:

Dominion Lending Centres Clearlease
HEAD OFFICE, Bentall Two, Suite 900, 555 Burrard Street, Vancouver, BC, V7X 1M8, CANADA.
Mr. Alexander Pidgeon, Editor in Chief
Tel: (604) 696-1221 ext. 199
eMail: [email protected]
Website: http://www.clearlease.com
News: http://clearlease.com/category/equipment-lease-blog/feed/rss
Twitter: @clearlease

###

Video Link: http://youtu.be/f_kk7WJa7Uk


Dominion Lending Centres Clearlease Reports Theratechnologies (TSX:TH) seeks European marketing for AIDS-related treatment drug Tesamorelin

VANCOUVER, BC (June 6, 2011) Dominion Lending Centres Clearlease Reports Theratechnologies Inc. (TSX:TH) says it has applied to sell its lead drug tesamorelin in Europe.

The Montreal company said Monday June 6, 2011 taht its partner, Ferrer Internacional S.A., has filed an application in Europe to market the drug, which treats excess abdominal fat in adult HIV-infected patients.

The drug has already received marketing approval in the United States.

Theratechnologies said there are no approved treatments to treat about 212,000 HIV-infected patients in Europe affected by lipodystrophy — a medical condition characterized by abnormal or degenerative loss of fat.

“This European regulatory filing for tesamorelin constitutes an important step forward in meeting our corporate objective of maximizing the commercial potential of our flagship product in major markets,” said John-Michel Huss, president and CEO of Theratechnologies.

“This also represents an important step towards addressing a critical, yet unmet medical need for HIV-infected patients with lipodystrophy throughout the European Union. We were very pleased to obtain FDA approval for tesamorelin in the U.S. and we are confident that our ability to help meet these patient needs, in partnership with Ferrer, will also be recognized in Europe.”

Under a distribution and licensing agreement between the two companies, privately owned Spanish drug maker Ferrer holds the commercialization rights to tesamorelin in Europe.

If approved, tesamorelin will receive marketing authorization for the 27 European Union member countries as well as for Iceland, Liechtenstein and Norway.

In trading on the Toronto Stock Exchange, Theratechnologies shares fell 10 cents to $4.34, a drop of 2.25 per cent.

Video Link: http://youtu.be/f_kk7WJa7Uk

For more information please visit us at: http://www.clearlease.com/Career-Opportunities.html

About Dominion Lending Centres Clearlease

Dominion Lending Centres Clearlease Commercial (DLC Clearlease/Clearlease.com) is a fully diversified Lease Finance Mortgage Banking Brokerage Company specializing in Equipment Leasing, Automobile Leasing, Residential, Commercial Lending/Mortgage Financing. DLC Clearlease possesses the capability to accommodate financing needs ranging from a small second Home Mortgage to a Multi-Million Dollar Commercial Projects. No mortgage is too small or too large for this integrated Company.

Equipment Lease Financing in Vancouver, Surrey, Delta, Richmond, Langley, New Westminster, North Vancouer, West Vancouver, B.C. Also offering Automobile Lease Financing and Mortgage information. Founded by the Pidgeon brothers.

You may have recently seen a Dominion Lending advertisement on such media outlets as: Global News, CTV News, CBC Television, Rogers Sportsnet or possibly heard the great Don Cherry, a Canadian Sports legend, discuss Dominion Lending Centres.

Contact DLC Clearlease.com:

Dominion Lending Centres Clearlease
HEAD OFFICE, Bentall Two, Suite 900, 555 Burrard Street, Vancouver, BC, V7X 1M8, CANADA.
Mr. Alexander Pidgeon, Editor in Chief
Tel: (604) 696-1221 ext. 199
eMail: [email protected]
Website: http://www.clearlease.com
News: http://clearlease.com/category/equipment-lease-blog/feed/rss
Twitter: @clearlease

###

Video Link: http://youtu.be/f_kk7WJa7Uk


Dominion Lending Centres Clearlease Reports Theratechnologies (TSX:TH) seeks European marketing for AIDS-related treatment drug Tesamorelin

VANCOUVER, BC (June 6, 2011) Dominion Lending Centres Clearlease Reports Theratechnologies Inc. (TSX:TH) says it has applied to sell its lead drug tesamorelin in Europe.

The Montreal company said Monday June 6, 2011 taht its partner, Ferrer Internacional S.A., has filed an application in Europe to market the drug, which treats excess abdominal fat in adult HIV-infected patients.

The drug has already received marketing approval in the United States.

Theratechnologies said there are no approved treatments to treat about 212,000 HIV-infected patients in Europe affected by lipodystrophy — a medical condition characterized by abnormal or degenerative loss of fat.

“This European regulatory filing for tesamorelin constitutes an important step forward in meeting our corporate objective of maximizing the commercial potential of our flagship product in major markets,” said John-Michel Huss, president and CEO of Theratechnologies.

“This also represents an important step towards addressing a critical, yet unmet medical need for HIV-infected patients with lipodystrophy throughout the European Union. We were very pleased to obtain FDA approval for tesamorelin in the U.S. and we are confident that our ability to help meet these patient needs, in partnership with Ferrer, will also be recognized in Europe.”

Under a distribution and licensing agreement between the two companies, privately owned Spanish drug maker Ferrer holds the commercialization rights to tesamorelin in Europe.

If approved, tesamorelin will receive marketing authorization for the 27 European Union member countries as well as for Iceland, Liechtenstein and Norway.

In trading on the Toronto Stock Exchange, Theratechnologies shares fell 10 cents to $4.34, a drop of 2.25 per cent.

Video Link: http://youtu.be/f_kk7WJa7Uk

For more information please visit us at: http://www.clearlease.com/Career-Opportunities.html

About Dominion Lending Centres Clearlease

Dominion Lending Centres Clearlease Commercial (DLC Clearlease/Clearlease.com) is a fully diversified Lease Finance Mortgage Banking Brokerage Company specializing in Equipment Leasing, Automobile Leasing, Residential, Commercial Lending/Mortgage Financing. DLC Clearlease possesses the capability to accommodate financing needs ranging from a small second Home Mortgage to a Multi-Million Dollar Commercial Projects. No mortgage is too small or too large for this integrated Company.

Equipment Lease Financing in Vancouver, Surrey, Delta, Richmond, Langley, New Westminster, North Vancouer, West Vancouver, B.C. Also offering Automobile Lease Financing and Mortgage information. Founded by the Pidgeon brothers.

You may have recently seen a Dominion Lending advertisement on such media outlets as: Global News, CTV News, CBC Television, Rogers Sportsnet or possibly heard the great Don Cherry, a Canadian Sports legend, discuss Dominion Lending Centres.

Contact DLC Clearlease.com:

Dominion Lending Centres Clearlease
HEAD OFFICE, Bentall Two, Suite 900, 555 Burrard Street, Vancouver, BC, V7X 1M8, CANADA.
Mr. Alexander Pidgeon, Editor in Chief
Tel: (604) 696-1221 ext. 199
eMail: [email protected]
Website: http://www.clearlease.com
News: http://clearlease.com/category/equipment-lease-blog/feed/rss
Twitter: @clearlease

###

Video Link: http://youtu.be/f_kk7WJa7Uk


Tags: No tags

Comments are closed.